MR1-restricted MAIT-cell population in chronic HIV-1 infection Activation, exhaustion, and persistent decline of the antimicrobial
暂无分享,去创建一个
Jeffrey N. Martin | A. Sönnerborg | S. Deeks | J. Andersson | Maire F. Quigley | B. Shacklett | E. Leeansyah | W. Hunt | J. Sandberg | A. Ganesh | Jeffrey N. Martin
[1] Malcolm J. McConville,et al. MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.
[2] D. Hoft,et al. Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate Functions in Bacterial Infection , 2012, Infection and Immunity.
[3] P. Streeter,et al. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress , 2012, Mucosal Immunology.
[4] James McCluskey,et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor , 2012, The Journal of experimental medicine.
[5] D. Douek,et al. Microbial translocation across the GI tract. , 2012, Annual review of immunology.
[6] S. Girardin,et al. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. , 2012, Trends in immunology.
[7] P. Klenerman,et al. Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. , 2012, Blood.
[8] A. Haase,et al. Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy , 2012, PLoS pathogens.
[9] T. Dong,et al. Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-γ Contributes to Modulate Immune Responses* , 2011, The Journal of Biological Chemistry.
[10] T. Yamamura,et al. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. , 2011, International immunology.
[11] Handan Wand,et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.
[12] J. Carlis,et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. , 2011, The Journal of clinical investigation.
[13] P. Georgel,et al. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. , 2011, Molecular immunology.
[14] O. Lantz,et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.
[15] S. Deeks,et al. HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.
[16] M. Moll,et al. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. , 2010, Blood.
[17] O. Lantz,et al. Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.
[18] J. Chmiel,et al. AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study , 2010, AIDS.
[19] Matthew S. Cook,et al. Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.
[20] A. Landay,et al. Early Immune Senescence in HIV Disease , 2010, Current HIV/AIDS reports.
[21] D. Fremont,et al. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution , 2009, Proceedings of the National Academy of Sciences.
[22] M. Lederman,et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.
[23] Veronica D. Gonzalez,et al. Severe functional impairment and elevated PD‐1 expression in CD1d‐restricted NKT cells retained during chronic HIV‐1 infection , 2009, European journal of immunology.
[24] O. Lantz,et al. Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.
[25] J. Margolick,et al. Immune activation and IL‐12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy , 2008, Journal of Leukocyte Biology.
[26] H. Sørensen,et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] Michael D. George,et al. Rapid Onset of Intestinal Epithelial Barrier Dysfunction in Primary Human Immunodeficiency Virus Infection Is Driven by an Imbalance between Immune Response and Mucosal Repair and Regeneration , 2007, Journal of Virology.
[28] B. Autran,et al. Accelerated immune senescence and HIV-1 infection , 2007, Experimental Gerontology.
[29] A. Sönnerborg,et al. Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection , 2007, AIDS.
[30] S. Crowe,et al. The Mechanism Underlying Defective Fcγ Receptor-Mediated Phagocytosis by HIV-1-Infected Human Monocyte-Derived Macrophages1 , 2007, The Journal of Immunology.
[31] M. Lederman,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.
[32] Daniel Doischer,et al. Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism. , 2006, AIDS research and human retroviruses.
[33] S. Gilfillan,et al. MR1-Restricted Vα19i Mucosal-Associated Invariant T Cells Are Innate T Cells in the Gut Lamina Propria That Provide a Rapid and Diverse Cytokine Response1 , 2006, The Journal of Immunology.
[34] F. Bihl,et al. Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor1 , 2005, The Journal of Immunology.
[35] C. Pradier,et al. In the era of highly active antiretroviral therapy, why are HIV‐infected patients still admitted to hospital for an inaugural opportunistic infection? , 2005, HIV medicine.
[36] Mario Roederer,et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.
[37] C. Sabin,et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy , 2004, AIDS.
[38] D. Price,et al. CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[39] Christine Hogan,et al. Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[40] D. Nixon,et al. Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection1 , 2004, The Journal of Immunology.
[41] J. Flamm,et al. Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[42] Julie Elliott,et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. , 2003, Journal of immunological methods.
[43] Olivier Lantz,et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.
[44] C. Macken,et al. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects , 2003, AIDS.
[45] Katherine Kedzierska,et al. HIV-1 Down-Modulates γ Signaling Chain of FcγR in Human Macrophages: A Possible Mechanism for Inhibition of Phagocytosis1 , 2002, The Journal of Immunology.
[46] R P Johnson,et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.
[47] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.